Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Pruritus | 16.1% - 27.6% | x | |
| Unspecified disorder of skin and subcutaneous tissue | 16.1% - 27.6% | x | |
| Hypotension | 2.19% - 6.71% | x | |
| Angiopathy | 2.19% - 6.71% | x | |
| Mediastinal disorder | 0.813% - 10.7% | x | |
| Hypoxemia | 0.813% - 10.7% | x | |
| Apnoea | x | ||
| Cough | x | ||
| Gastrointestinal disorder | x | ||
| Headache | x | ||
| Nausea | x | ||
| Nervous system disorder | x | ||
| Paraesthesia | x | ||
| Vomiting | x | ||
| Respiratory depression | x | ||
| Stinging | x | ||
| Non-sustained ventricular tachycardia | x | ||
| Hepatic insufficiency | x | ||
| Procedural pain | 0% - 2.01% | x | |
| Tingling sensation | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Acute myeloid leukaemia | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |